Literature DB >> 25527263

Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma.

Caroline Houillier1, Sylvain Choquet1, Valerie Touitou1, Nadine Martin-Duverneuil1, Soledad Navarro1, Karima Mokhtari1, Carole Soussain1, Khê Hoang-Xuan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25527263     DOI： 10.1212/WNL.0000000000001158

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  26 in total

1.  Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial.

Authors:  Jorg Dietrich; Laura Versmee; Jan Drappatz; April F Eichler; Lakshmi Nayak; Andrew Norden; Eric Wong; Michelle R Pisapia; SooAe S Jones; Amanda B Gordon; Bruce A Chabner; Fred Hochberg; Tracy T Batchelor
Journal:  Oncologist       Date:  2020-07-01

2.  Identifying targetable genetic features in primary CNS lymphoma.

Authors:  Agnieszka Korfel; Uwe Schlegel
Journal:  Int J Hematol Oncol       Date:  2017-01-13

Review 3.  Advances in Primary Central Nervous System Lymphoma.

Authors:  Lauren B Patrick; Nimish A Mohile
Journal:  Curr Oncol Rep       Date:  2015-12       Impact factor: 5.075

Review 4.  Introduction of novel agents in the treatment of primary CNS lymphoma.

Authors:  Christian Grommes; Lakshmi Nayak; Han W Tun; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

5.  Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).

Authors:  Francisco-Javier Peñalver; Juan-Manuel Sancho; Adolfo de la Fuente; María-Teresa Olave; Alejandro Martín; Carlos Panizo; Elena Pérez; Antonio Salar; Alberto Orfao
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

Review 6.  Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents.

Authors:  Andrés José María Ferreri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 7.  Primary central nervous system lymphoma.

Authors:  Tracy T Batchelor
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

8.  Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

Authors:  Sophie Langner-Lemercier; Caroline Houillier; Carole Soussain; Hervé Ghesquières; Olivier Chinot; Luc Taillandier; Pierre Soubeyran; Thierry Lamy; Franck Morschhauser; Alexandra Benouaich-Amiel; Guido Ahle; Marie-Pierre Moles-Moreau; Cécile Moluçon-Chabrot; Pascal Bourquard; Ghandi Damaj; Fabrice Jardin; Delphine Larrieu; Emmanuel Gyan; Remy Gressin; Arnaud Jaccard; Sylvain Choquet; Annie Brion; Olivier Casasnovas; Philippe Colin; Oumedaly Reman; Adrian Tempescul; Jean-Pierre Marolleau; Michel Fabbro; Florian Naudet; Khê Hoang-Xuan; Roch Houot
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

9.  Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.

Authors:  Caroline Houillier; Hervé Ghesquières; Cécile Chabrot; Carole Soussain; Guido Ahle; Sylvain Choquet; Emmanuelle Nicolas-Virelizier; Jacques-Olivier Bay; Jacques Vargaftig; Claude Gaultier; Valérie Touitou; Nadine Martin-Duverneuil; Nathalie Cassoux; Magali Le Garff-Tavernier; Myrto Costopoulos; Pierre Faurie; Khê Hoang-Xuan
Journal:  J Neurooncol       Date:  2017-04-21       Impact factor: 4.130

10.  Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia.

Authors:  Paolo Strati; Joon H Uhm; Timothy J Kaufmann; Chadi Nabhan; Sameer A Parikh; Curtis A Hanson; Kari G Chaffee; Timothy G Call; Tait D Shanafelt
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.